On ECHEMI
Home > Drugs > Dapagliflozin Registered Holders
Dapagliflozin structure

Dapagliflozin structure

Dapagliflozin

Dapagliflozin (BMS-512148) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

Find 81 Related Holders

METROCHEM API PRIVATE LTD
United States United States

API Registration Country

API Active
MICRO LABS LTD
United States United States

API Registration Country

API Active
AZICO BIOPHORE INDIA PVT LTD
United States United States

API Registration Country

API Active
OPTIMUS DRUGS PRIVATE LTD
United States United States

API Registration Country

API Active
HONOUR LAB LTD
United States United States

API Registration Country

API Active
SCL LIFESCIENCES LTD
United States United States

API Registration Country

API Active
LEE PHARMA LTD
United States United States

API Registration Country

API Active
AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)
United States United States

API Registration Country

API Active
LAURUS LABS LTD
United States United States

API Registration Country

API Active
RAKS PHARMA PVT LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Dapagliflozin
View 145 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.